Akebia Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-253.0M | $-253.0M | $59.0K | $22.7M |
| FY2022 | $-73.2M | $-73.3M | $114.0K | $17.8M |
| FY2023 | $-23.4M | $-23.4M | $0 | $9.3M |
| FY2024 | $-40.7M | $-40.7M | $33.0K | $7.8M |
| FY2025 | $68.0M | $67.7M | $291.0K | $11.3M |